Apricus Biosciences (NASDAQ:APRI)

CAPS Rating: 2 out of 5

A pharmaceutical and medical technology company, which conducts research and development both domestically and abroad on proprietary pharmaceutical products.


Player Avatar etra (< 20) Submitted: 11/17/2012 4:33:26 PM : Outperform Start Price: $2.18 APRI Score: -100.75

At present most players of APRI stock buy and then sell almost on a daily basis.The company should convince investment groups that future earnings should enable them to carry the price to $5.00 ..

Featured Broker Partners